IL-13[Biotin], His & Avi, Human
¥5800 | |
Z04492-100 | |
|
|
|
|
|
¥5800 | |
Z04492-100 | |
|
|
|
|
|
Species | Human | ||||||
Protein Construction |
|
||||||
Conjugate | Biotin | ||||||
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||||
Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
Biological Activity | Measured by its binding ability in a functional ELISA. Immobilized IL-13[Biotin], His & Avi, Human at 5μg/ml (100μl/Well) on streptavidin (5μg/ml) precoated plate can bind Human IL13Ra2, hFc Tag. Test result was comparable to standard batch. | ||||||
Expression System | HEK293 | ||||||
Theoretical Molecular Weight | 15.3 kDa | ||||||
Apparent Molecular Weight | Due to glycosylation, the protein migrates to 15 kDa and 35-45 kDa based on Bis-Tris PAGE result. | ||||||
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Immobilized IL-13[Biotin], His & Avi, Human, His Avi Tag at 5 μg/ml(100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Human IL-13Ra2, hFc Tag with the EC50 of 0.81 μg/ml determined by ELISA. »
The purity of IL-13[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
IL-13[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%. »
Human IL-13Ra1, hFc Tag captured on CM5 Chip via Protein A can bind IL-13[Biotin], His & Avi, Human, His Tag with an affinity constant of 25.59 nM as determined in SPR assay (Biacore T200). »
Target Background | Interleukin-13 (IL-13) is a monomeric 17 kDa immunoregulatory cytokine that plays a key role in the pathogenesis of allergy, cancer, and tissue fibrosis. It is secreted by several helper T cell subsets, NK cells, mast cells, eosinophils, basophils, and visceral smooth muscle cells. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages (By similarity). |
Synonyms | IL13; IL-13; interleukin 13; NC30; P600; ALRH; BHR1; MGC116786; MGC116788; MGC116789 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.